PA
NIO icon

PharVision Advisers’s NIO NIO Stock Holding History

PharVision Advisers’s Portfolio NIO Stock Details NIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98K Sell
16,259
-94,285
-85% -$476K 0.99% 49
2025
Q4 		$564K Buy
110,544
+90,212
+444% +$557K 0.29% 22
2025
Q3 		$155K Buy
+20,332
New +$110K 0.09% 566

Other funds holding NIO

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's NIO Position: Q1 2026 in Review

PharVision Advisers reduced its NIO (NIO) stake by 85% in Q1 2026, selling an estimated $476K and leaving 16,259 shares worth $98K. The position accounts for 0.99% of the portfolio, ranked #49.

PharVision Advisers first reported a position in NIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $564K in Q4 2025. 432 funds tracked by Wall St. Rank hold NIO as of Q1 2026.

  • PharVision Advisers held 16,259 shares of NIO worth $98K as of Q1 2026.
  • PharVision Advisers sold 94,285 NIO shares in Q1 2026, an estimated $476K.
  • NIO made up 0.99% of PharVision Advisers's portfolio in Q1 2026, its #49 holding.
  • PharVision Advisers first reported a position in NIO in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's NIO position peaked at $564K in Q4 2025.
  • 432 funds tracked by Wall St. Rank held NIO as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.